After 30 years of development, the China’s diagnostic reagent industry achieved a market size of nearly RMB 20 billion in 2014, a YoY growth of 15.7%. Currently nearly 90% downstream users of China’s diagnostic reagent market comes from hospitals.

There’s still a huge growth potential in China’s diagnostic reagent industry. China accounts for 20% of total population worldwide, but only take up 7% of global diagnostic reagent market in 2014. The average diagnostic reagent expense in China is only around $3, far below the average of $28 in the developed countries.

Currently there are about 300 diagnostic reagent enterprises in China and the industry concentration is still low. Large companies in China include: KHB, Da An Gene, Maker, HTA etc. Foreign brands accounts for over 50% of China’s diagnostic reagent market in 2014, especially in high-end fields. The market share of domestic enterprises mainly comes from biochemical reagents.

China has fulfilled the import substitution of biochemical reagents, intensified competition has largely squeezed the profits in this subfield. Chemiluminescence Immunoassay (CLIA) and molecular diagnosis will be the most promising subfields in China’s diagnostic reagent industry.

New Industries Biomedical Engineering Co., Ltd is the leading CLIA enterprise in China. Currently the company owns 102 chemiluminescent reagents and 8 models of CLIA analyzer. The company achieved reagents sales of RMB 331 million and reagents products has exported to Swiss, France, and Italy etc.

Zeesan Biotech is the leading molecular diagnosis enterprise in China. The company achieved molecular diagnosis reagents sales of RMB 11.85 million in 2014. Zeesan’s products covers infectious disease (mainly phthisis), tumor (mainly leukemia) and genetic disease.

Table of Contents

1 Overview
1.1 Classification
1.2 Policy
1.3 Industry Chain

2 Market Landscape
2.1 Overview
2.2 Market Segement
2.2.1 Immunodiagnosis
2.2.2 Molecular Diagnosis
2.2.3 Biochemical Diagnosis
2.3 Competition
2.4 Import & Export
2.4.1 Import
2.4.2 Export

3 Major Enterprises
3.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
3.1.1 Company Profile
3.1.2 Key Financial Data
3.1.3 Competitiveness Analysis
3.1.7 Diagnostic Reagent Business
3.2 Beijing Strong Biotechnologies, Inc (BSBE)
3.2.1 Profile
3.2.2 Key Financial Data
3.2.3 Competitiveness Analysis
3.2.4 Diagnostic Reagent Business
3.3 Da An Gene
3.3.1 Company Profile
3.3.2 Key Financial Data
3.3.3 Competitiveness Analysis
3.3.4 Diagnostic Reagent Business
3.4 Fosun Pharmaceutical
3.4.1 Company Profile
3.4.2 Key Financial Data
3.4.3 Competitiveness Analysis
3.4.4 Diagnostic Reagent Business
3.5 Beijing Leadman Biochemistry Co., Ltd.
3.5.1 Company Profile
3.5.2 Key Financial Data
3.5.3 Competitiveness Analysis
3.5.4 Diagnostic Reagent Business
3.6 Livzon Pharmaceutical Group Inc.
3.6.1 Company Profile
3.6.2 Key Financial Data
3.6.3 Competitiveness Analysis
3.6.4 Diagnostic Reagent Business
3.7 Mindray Medical
3.7.1 Company Profile
3.7.2 Key Financial Data
3.7.3 Competitiveness Analysis
3.7.4 Diagnostic Reagent Business
3.8 Biosino Bio-Technology & Science Inc.
3.8.1 Company Profile
3.8.2 Key Financial Data
3.8.3 Competitiveness Analysis
3.8.4 Diagnostic Reagent Business
3.9 Maker Biotechnology
3.9.1 Company Profile
3.9.2 Key Financial Data
3.9.3 Competitiveness Analysis
3.9.4 Diagnostic Reagent Business
3.10 Sinocare
3.10.1 Company Profile
3.10.2 Key Financial Data
3.10.3 Competitiveness Analysis
3.10.4 Diagnostic Reagent Business
3.11 Beijing Kinghawk Pharmaceutical Co., Ltd.
3.11.1 Company Profile
3.11.2 Key Financial Data
3.11.3 Competitiveness Analysis
3.11.4 Diagnostic Reagent Business
3.12 Bohui Innovation
3.12.1 Company Profile
3.12.2 Key Financial Data
3.12.3 Competitiveness Analysis
3.12.4 Diagnostic Reagent Business
3.13 Health BioMed
3.13.1 Company Profile
3.13.2 Key Financial Data
3.13.3 Competitiveness Analysis
3.13.4 Diagnostic Reagent Business
3.14 Wondfo
3.14.1 Company Profile
3.14.2 Key Financial Data
3.14.3 Competitiveness Analysis
3.14.4 Diagnostic Reagent Business
3.15 Thalys
3.15.1 Company Profile
3.15.2 Key Financial Data
3.15.3 Competitiveness Analysis
3.15.4 Diagnostic Reagent Business
3.16 SHINVA
3.16.1 Company Profile
3.16.2 Key Financial Data
3.16.3 Competitiveness Analysis
3.16.4 Diagnostic Reagent Business
3.17 Humanwell Healthcare
3.17.1 Company Profile
3.17.2 Key Financial Data
3.17.3 Diagnostic Reagent Business
3.18 HTA CO. LTD
3.18.1 Company Profile
3.18.2 Key Financial Data
3.18.3 Diagnostic Reagent Business
3.19 New Indutries Biomedical Engineering
3.19.1 Company Profile
3.19.2 Key Financial Data
3.19.3 Diagnostic Reagent Business
3.20 Sichuan Xincheng Biological
3.20.1 Company Profile
3.20.2 Key Financial Data
3.20.3 Diagnostic Reagent Business
3.21 MultiSciences Biotech
3.21.1 Company Profile
3.21.2 Key Financial Data
3.21.3 Diagnostic Reagent Business
3.22 Surexam
3.22.1 Company Profile
3.22.2 Key Financial Data
3.22.3 Diagnostic Reagent Business
3.23 Shanghai Kexin Biotech
3.23.1 Company Profile
3.23.2 Key Financial Data
3.23.3 Diagnostic Reagent Business
3.24 Shanghai Fenghui Medical Science and Technology
3.24.1 Company Profile
3.24.2 Key Financial Data
3.24.3 Diagnostic Reagent Business
3.25 Beijing The Place Bio-Tech
3.25.1 Company Profile
3.25.2 Key Financial Data
3.25.3 Diagnostic Reagent Business
3.26 Beijing The Place Bio-Tech
3.26.1 Company Profile
3.26.2 Key Financial Data
3.26.3 Diagnostic Reagent Business
3.27 Shanghai GenePharma
3.27.1 Company Profile
3.27.2 Key Financial Data
3.27.3 Diagnostic Reagent Business
3.28 Suzhou GenePharma
3.28.1 Company Profile
3.28.2 Key Financial Data
3.28.3 Diagnostic Reagent Business
3.29 EasyDiagnosis Biomedicine
3.29.1 Company Profile
3.29.2 Key Financial Data
3.29.3 Diagnostic Reagent Business
3.30 King Diagnostic Technology
3.30.1 Company Profile
3.30.2 Key Financial Data
3.30.3 Diagnostic Reagent Business
3.31 Zeesan Biotech
3.31.1 Company Profile
3.31.2 Key Financial Data
3.31.3 Diagnostic Reagent Business
3.32 Baibo Biotechnology
3.32.1 Company Profile
3.32.2 Key Financial Data
3.32.3 Diagnostic Reagent Business
3.33 Nymphavn Biotechnology
3.33.1 Company Profile
3.33.2 Key Financial Data
3.33.3 Diagnostic Reagent Business
3.34 Shuguang HZK Biological Technology
3.34.1 Company Profile
3.34.2 Key Financial Data
3.34.3 Diagnostic Reagent Business
3.35 Medicalsystem Biotechnology
3.35.1 Company Profile
3.35.2 Key Financial Data
3.35.3 Diagnostic Reagent Business

4 Industry Main Indicator

List of Charts

Classification of In Vitro Diagnostic Reagents (by Detection Principle)
2005-2013 Main Policies of China Diagnostic Reagent Industry
Industry Chain of Diagnostic Reagent
2009-2014 Market Size of In Vitro Diagnostics in China
2014 Market Structure of China’s In Vitro Diagnostic Reagent
2010-2015 Market Size of China’s Immunodiagnosis Market by Products
Domestic Enterprises with Chemiluminescence Immunoassay (CLIA) Products
Numbers of DLIA Diagnostic Reagents by Domestic Enterprises
2007-2013 Numbers of Molecular Diagnosis Project in China
2010-2015 Market Size of Biochemical Diagnosis in China
Diagnostic Instrument Comparison between Domestic and Foreign Enterprises
Competition Pattern of China’s Diagnostic Reagent Industry
Development Strategies of Leading Diagnostic Reagent Companies Worldwide
2009-2013 Gross Margin Comparison between Major Diagnostic Reagent Companies in China
2009-2014 Revenue Comparison between Major In Vitro Diagnostics Companies in China
2008-2014 Import Volume of China’s Diagnostic Reagent
2008-2014 Import Value of China’s Diagnostic Reagent
2012-2014 Import Sources and Value of China’s Diagnostic Reagent
2008-2014 Export Volume of China’s Diagnostic Reagent
2008-2014 Export Value of China’s Diagnostic Reagent
2012-2014 Export Volume and Value of Chinese Diagnostic Reagents by Countries
2009-2014 Revenue and Net Income of KHB
2009-2014 Revenue Structure of KHB by Product
2009-2014 Gross Margin of KHB by Product